Literature DB >> 22213323

Association of genetic variants of the vitamin D receptor (VDR) with cutaneous squamous cell carcinomas (SCC) and basal cell carcinomas (BCC): a pilot study in a German population.

Kim Köstner1, Nicole Denzer, Milena Koreng, Sandra Reichrath, Stefan Gräber, Rolf Klein, Wolfgang Tilgen, Thomas Vogt, Jörg Reichrath.   

Abstract

BACKGROUND: Vitamin D receptor (VDR) polymorphisms have important implications for vitamin D signalling and are associated with various malignancies. PATIENTS AND METHODS: In a German population, the frequency of several VDR polymorphisms (Apa1, Taq1, Bgl1) in basal cell carcinomas (BCCs, n=90) and cutaneous squamous cell carcinomas (SCCs, n=100) as compared to healthy controls (n=51) was analyzed.
RESULTS: Impressive variations in the frequency of some VDR genotypes were found when comparing skin of cancer patients and controls. An association of the genotype AaTtBb with BCC risk was found (BCC: 45.7%, SCC: 39.8% and controls: 38.0%). The genotype aaTTBB was exclusively found in the control group (20%), which suggested that this genotype may be protective against skin carcinogenesis. Moreover, the aaTTbb genotype was associated with skin cancer risk, being found at a much higher frequency in BCCs (21%) and SCCs (17%) as compared to controls (8.0%). Comparison of the frequencies of the VDR genotypes in sunlight-exposed vs. not sunlight-exposed skin areas revealed BB 30.1% vs. 7.1% respectively in BCCs and BB 28.1% vs. 0.0% respectively in SCCs, indicating that vitamin D signalling may be of importance for photocarcinogenesis of the skin. Associations also indicated that the Apa1 and Taq1 genotypes may be of importance for photocarcinogenesis of BCCs, but not for SCCs. Comparison of the VDR genotype frequencies by age (younger than 60 years vs. 60 years or older) revealed no evidence of age-dependent variations in patients with BCCs or SCCs.
CONCLUSION: VDR polymorphisms are of importance for the development of BCCs and cutaneous SCCs, but further explorations of these findings and their implications are required.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22213323

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  11 in total

Review 1.  Skeletal and Extraskeletal Actions of Vitamin D: Current Evidence and Outstanding Questions.

Authors:  Roger Bouillon; Claudio Marcocci; Geert Carmeliet; Daniel Bikle; John H White; Bess Dawson-Hughes; Paul Lips; Craig F Munns; Marise Lazaretti-Castro; Andrea Giustina; John Bilezikian
Journal:  Endocr Rev       Date:  2019-08-01       Impact factor: 19.871

2.  A population-based study of hedgehog pathway gene variants in relation to the dual risk of basal cell carcinoma plus another cancer.

Authors:  Timothy J Jorgensen; Ingo Ruczinski; Yin Yao Shugart; Lee Wheless; Yvette Berthier Schaad; Bailey Kessing; Judith Hoffman-Bolton; Kathy J Helzlsouer; W H Linda Kao; Lesley Francis; Rhoda M Alani; Paul T Strickland; Michael W Smith; Anthony J Alberg
Journal:  Cancer Epidemiol       Date:  2012-06-05       Impact factor: 2.984

Review 3.  Targeting the vitamin D endocrine system (VDES) for the management of inflammatory and malignant skin diseases: An historical view and outlook.

Authors:  Jörg Reichrath; Christos C Zouboulis; Thomas Vogt; Michael F Holick
Journal:  Rev Endocr Metab Disord       Date:  2016-09       Impact factor: 6.514

Review 4.  The Role of Classical and Novel Forms of Vitamin D in the Pathogenesis and Progression of Nonmelanoma Skin Cancers.

Authors:  Andrzej T Slominski; Anna A Brożyna; Michal A Zmijewski; Zorica Janjetovic; Tae-Kang Kim; Radomir M Slominski; Robert C Tuckey; Rebecca S Mason; Anton M Jetten; Purushotham Guroji; Jörg Reichrath; Craig Elmets; Mohammad Athar
Journal:  Adv Exp Med Biol       Date:  2020       Impact factor: 2.622

Review 5.  Nuclear hormone receptor functions in keratinocyte and melanocyte homeostasis, epidermal carcinogenesis and melanomagenesis.

Authors:  Stephen Hyter; Arup K Indra
Journal:  FEBS Lett       Date:  2013-02-05       Impact factor: 4.124

6.  Association of Vitamin D Receptor Polymorphisms With the Risk of Nonmelanoma Skin Cancer in Adults.

Authors:  Erin M Burns; Purushotham Guroji; Israr Ahmad; Hana M Nasr; Yingxue Wang; Iman A Tamimi; Elijah Stiefel; Mohammad S Abdelgawwad; Abdullah Shaheen; Anum F Muzaffar; Lisa M Bush; Christina B Hurst; Russell L Griffin; Craig A Elmets; Nabiha Yusuf
Journal:  JAMA Dermatol       Date:  2017-10-01       Impact factor: 10.282

Review 7.  Vitamin D and Vitamin D Analogs as Adjuncts to Field Therapy Treatments for Actinic Keratoses: Current Research and Future Approaches.

Authors:  Zafer Sattouf; Steven J Repas; Jeffrey B Travers; Craig A Rohan
Journal:  J Skin Cancer       Date:  2021-06-19

8.  Meta-analysis on vitamin D receptor and cancer risk: focus on the role of TaqI, ApaI, and Cdx2 polymorphisms.

Authors:  Davide Serrano; Patrizia Gnagnarella; Sara Raimondi; Sara Gandini
Journal:  Eur J Cancer Prev       Date:  2016-01       Impact factor: 2.497

9.  Vitamin D Receptor Gene Polymorphism In Chronic Telogen Effluvium; A Case-Control Study.

Authors:  Iman Seleit; Ola A Bakry; Eman Badr; Eman H Hassan
Journal:  Clin Cosmet Investig Dermatol       Date:  2019-10-08

Review 10.  The relevance of the vitamin D endocrine system (VDES) for tumorigenesis, prevention, and treatment of non-melanoma skin cancer (NMSC): Present concepts and future perspectives.

Authors:  Jörg Reichrath; Sandra Reichrath
Journal:  Dermatoendocrinol       Date:  2013-01-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.